Healthcare Stocks
The largest healthcare and biotech companies listed in the US. Updated October 10, 2026.
Summary
The Healthcare Stocks list currently includes 100 companies. The top 3 are Eli Lilly (LLY) ($1.1T market cap), Johnson & Johnson (JNJ) ($630.0B market cap) and AbbVie (ABBV) ($488.6B market cap).
Combined, the companies shown are worth $8.11T, with a median market cap of $31.4B.
On the latest trading day, 87 of 100 were higher, with an average move of +1.61%.
The median trailing P/E ratio is 27.0x across the 80 profitable companies.
51 pay a dividend, with an average yield of 2.18%.
Summary generated from market data by MetaCap's automated system. Methodology
Healthcare Stocks
| # | Symbol | Company | Price | % Change | Volume | Market Cap | P/E | Div. Yield |
|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and | 1,179.27 | +0.83% | 1.38M | $1.05T | 39.6 | 0.59% |
| 2 | JNJ | Johnson & Johnson | 261.44 | +1.93% | 5.46M | $630.04B | 30.3 | 2.05% |
| 3 | ABBV | AbbVie | 276.47 | +1.49% | 4.26M | $488.55B | 78.1 | 2.50% |
| 4 | MRK | Merck & | 145.60 | +2.26% | 8.00M | $359.22B | 115.6 | 2.34% |
| 5 | UNH | UnitedHealth | 379.30 | +2.25% | 7.44M | $340.46B | 24.4 | 2.45% |
| 6 | PM | Philip Morris International | 201.19 | +0.34% | 3.24M | $313.58B | 28.9 | 3.18% |
| 7 | NVS | Novartis | 143.75 | +0.45% | 1.90M | $273.23B | 21.7 | 3.30% |
| 8 | AZN | AstraZeneca | 159.20 | +0.26% | 2.06M | $246.90B | 23.8 | 2.01% |
| 9 | AMGN | Amgen | 414.87 | +1.82% | 2.01M | $224.29B | 25.8 | 2.43% |
| 10 | GILD | Gilead Sciences | 151.17 | +2.77% | 5.33M | $187.44B | — | 2.17% |
| 11 | ABT | Abbott Laboratories | 99.60 | +1.13% | 6.96M | $172.35B | 32.1 | 2.53% |
| 12 | NVO | Novo Nordisk A/S | 38.64 | +1.20% | 9.38M | $170.57B | 9.4 | 4.65% |
| 13 | PFE | Pfizer | 28.28 | +1.65% | 22.60M | $161.19B | 37.2 | 6.08% |
| 14 | ISRG | Intuitive Surgical | 423.96 | +2.06% | 1.76M | $149.78B | 47.6 | — |
| 15 | VRTX | Vertex Pharmaceuticals | 510.08 | +1.36% | 1.47M | $129.29B | 29.7 | — |
| 16 | BMY | Bristol-Myers Squibb | 59.12 | -0.77% | 9.25M | $120.77B | 13.0 | 4.26% |
| 17 | MO | Altria | 71.68 | +0.36% | 8.37M | $119.69B | 15.1 | 6.19% |
| 18 | BTI | British American Tobacco Industries p.l.c. | 55.50 | +0.13% | 2.60M | $119.38B | 14.2 | 6.02% |
| 19 | MDT | Medtronic | 88.48 | +0.83% | 38.86M | $113.18B | 21.7 | 3.26% |
| 20 | MCK | McKesson | 938.84 | +0.92% | 482.89K | $109.46B | 25.2 | 0.40% |
| 21 | SYK | Stryker | 277.33 | +0.13% | 1.48M | $106.38B | 28.7 | 1.27% |
| 22 | HCA | HCA Healthcare | 451.09 | +1.37% | 980.82K | $97.66B | 15.1 | 0.69% |
| 23 | SNY | Sanofi ADS | 40.07 | -0.40% | 2.10M | $96.01B | 21.1 | 6.04% |
| 24 | GSK | GSK ADR | 46.50 | -0.09% | 8.43M | $93.16B | 14.7 | 3.91% |
| 25 | MRNA | Moderna | 225.00 | +14.21% | 28.82M | $89.83B | — | — |
| 26 | ELV | Elevance Health | 412.70 | +2.93% | 2.08M | $89.50B | 18.3 | 1.67% |
| 27 | MMM | 3M | 159.96 | -2.21% | 2.37M | $82.49B | 28.4 | 1.95% |
| 28 | REGN | Regeneron Pharmaceuticals | 746.54 | +0.94% | 466.00K | $76.86B | 18.5 | 0.50% |
| 29 | CI | Cigna | 282.43 | +0.50% | 885.36K | $74.63B | 11.7 | 2.21% |
| 30 | BSX | Boston Scientific | 42.73 | +1.64% | 12.76M | $61.93B | 17.3 | — |
| 31 | COR | Cencora | 323.85 | +0.78% | 775.05K | $61.80B | 24.0 | 0.74% |
| 32 | TAK | Takeda Pharmaceutical ADR | 18.73 | +1.13% | 2.04M | $59.83B | — | 3.29% |
| 33 | NTRA | Natera | 400.71 | +2.54% | 1.01M | $57.76B | — | — |
| 34 | CAH | Cardinal Health | 237.57 | -0.58% | 1.03M | $55.01B | 32.9 | 0.87% |
| 35 | ARGX | argenx ADR | 825.03 | +0.78% | 512.22K | $51.88B | 31.4 | — |
| 36 | HUM | Humana | 431.87 | +11.56% | 4.99M | $51.86B | 40.8 | 0.82% |
| 37 | BDX | Becton Dickinson and | 183.75 | +0.55% | 1.20M | $50.05B | 42.7 | 2.29% |
| 38 | EW | Edwards Lifesciences | 85.21 | +1.15% | 3.89M | $49.12B | 50.7 | — |
| 39 | MDLN | Medline | 36.26 | +1.45% | 5.33M | $48.79B | 90.6 | — |
| 40 | TEVA | Teva Pharmaceutical Industries | 41.10 | +4.71% | 14.36M | $47.93B | 68.5 | — |
| 41 | IQV | IQVIA | 259.88 | +0.39% | 972.31K | $42.78B | 32.3 | — |
| 42 | ILMN | Illumina | 278.17 | +5.14% | 1.89M | $42.00B | 51.9 | — |
| 43 | IDXX | IDEXX Laboratories | 518.00 | +0.95% | 466.76K | $40.81B | 36.4 | — |
| 44 | RVMD | Revolution Medicines | 189.76 | +0.87% | 2.21M | $40.67B | — | — |
| 45 | ONC | BeOne Medicines ADR | 354.47 | +1.24% | 191.37K | $40.33B | 63.4 | — |
| 46 | BIIB | Biogen | 225.71 | +3.33% | 814.92K | $33.35B | 40.1 | — |
| 47 | RPRX | Royalty Pharma | 56.93 | +1.28% | 2.69M | $32.90B | 30.3 | 1.65% |
| 48 | RMD | ResMed | 230.05 | +1.46% | 979.65K | $32.35B | 22.1 | 1.15% |
| 49 | CNC | Centene | 65.36 | +1.27% | 2.85M | $32.29B | — | — |
| 50 | DXCM | DexCom | 84.11 | -0.36% | 3.11M | $31.74B | 33.4 | — |
| 51 | ALNY | Alnylam Pharmaceuticals | 232.68 | +3.63% | 859.92K | $31.13B | 39.2 | — |
| 52 | ALC | Alcon | 64.11 | +1.55% | 1.28M | $30.99B | 48.6 | 0.56% |
| 53 | ZTS | Zoetis | 74.81 | +2.37% | 2.89M | $30.91B | 12.0 | 2.83% |
| 54 | GEHC | GE HealthCare Technologies | 65.74 | +2.37% | 2.86M | $29.69B | 15.1 | 0.24% |
| 55 | WST | West Pharmaceutical Services | 366.00 | +0.75% | 480.20K | $25.76B | 46.9 | 0.24% |
| 56 | ROIV | Roivant Sciences | 35.44 | +3.60% | 5.53M | $25.60B | — | — |
| 57 | DGX | Quest Diagnostics | 230.97 | +0.07% | 775.43K | $25.49B | 24.5 | 1.49% |
| 58 | LH | Labcorp | 312.15 | -0.65% | 607.85K | $25.32B | 26.0 | 0.92% |
| 59 | BNTX | BioNTech ADR | 96.96 | +5.32% | 1.29M | $24.36B | — | — |
| 60 | PHG | Koninklijke Philips N.V. NY Registry Shares | 24.24 | -0.25% | 3.33M | $23.69B | 18.1 | 4.18% |
| 61 | UTHR | United Therapeutics | 549.16 | +3.07% | 562.00K | $23.55B | 19.7 | — |
| 62 | INCY | Incyte | 112.79 | +0.04% | 1.12M | $22.86B | 14.4 | — |
| 63 | GMAB | Genmab A/S ADS | 37.07 | +2.83% | 2.33M | $22.79B | 28.5 | — |
| 64 | GH | Guardant Health | 167.47 | +1.15% | 1.52M | $22.47B | — | — |
| 65 | INSM | Insmed | 100.60 | +0.12% | 2.47M | $21.97B | — | — |
| 66 | THC | Tenet Healthcare | 263.78 | +1.23% | 522.65K | $21.24B | 10.2 | — |
| 67 | STE | STERIS Ireland | 214.40 | +1.73% | 596.97K | $20.90B | 26.2 | 1.20% |
| 68 | VTRS | Viatris | 17.64 | +1.15% | 8.83M | $20.26B | — | 2.72% |
| 69 | MEDP | Medpace | 612.05 | +1.55% | 159.76K | $17.08B | 35.9 | — |
| 70 | ZBH | Zimmer Biomet | 89.14 | +0.29% | 1.60M | $17.00B | 21.6 | 1.08% |
| 71 | ASND | Ascendis Pharma A/S | 229.23 | +2.94% | 815.73K | $15.08B | 17.1 | — |
| 72 | SOLV | Solventum | 87.29 | +1.02% | 1.06M | $14.86B | 10.7 | — |
| 73 | EXEL | Exelixis | 59.86 | +1.42% | 2.67M | $14.83B | 18.9 | — |
| 74 | CRL | Charles River Laboratories International | 301.79 | +1.27% | 679.78K | $14.54B | — | — |
| 75 | NBIX | Neurocrine Biosciences | 142.44 | +0.84% | 1.02M | $14.48B | 20.9 | — |
| 76 | JAZZ | Jazz Pharmaceuticals | 218.42 | -1.81% | 1.29M | $14.18B | 15.0 | — |
| 77 | ULS | UL Solutions | 69.99 | -0.93% | 748.42K | $14.13B | 28.2 | 0.83% |
| 78 | SMMT | Summit Therapeutics | 17.59 | +2.45% | 5.75M | $14.03B | — | — |
| 79 | CORT | Corcept Therapeutics | 121.19 | +2.24% | 496.52K | $13.10B | 269.3 | — |
| 80 | BBIO | BridgeBio Pharma | 65.35 | +0.48% | 1.85M | $12.78B | — | — |
| 81 | ICLR | ICON | 164.17 | -0.20% | 712.87K | $12.67B | 172.8 | — |
| 82 | BTSG | BrightSpring Health Services | 63.74 | +0.13% | 1.61M | $12.61B | 56.4 | — |
| 83 | BAX | Baxter International | 24.35 | +1.88% | 3.01M | $12.59B | — | 0.16% |
| 84 | PEN | Penumbra | 319.40 | +0.59% | 555.29K | $12.58B | 78.5 | — |
| 85 | HALO | Halozyme Therapeutics | 110.42 | +0.53% | 1.85M | $12.53B | 32.3 | — |
| 86 | EHC | Encompass Health | 123.33 | +0.64% | 604.36K | $12.17B | 20.5 | 0.68% |
| 87 | ELAN | Elanco Animal Health | 22.92 | +1.69% | 2.52M | $11.45B | — | — |
| 88 | DVA | DaVita | 179.25 | +1.26% | 369.64K | $11.44B | 15.1 | — |
| 89 | SNN | Smith & Nephew SNATS | 27.24 | +1.04% | 982.89K | $11.40B | 18.5 | 2.91% |
| 90 | TECH | Bio-Techne | 72.46 | +0.01% | 2.23M | $11.36B | 62.5 | 0.44% |
| 91 | FMS | Fresenius Medical Care ADR | 21.06 | +0.86% | 1.01M | $11.21B | 10.9 | 4.14% |
| 92 | PCVX | Vaxcyte | 71.38 | +9.79% | 4.38M | $11.15B | — | — |
| 93 | IBRX | ImmunityBio | 10.51 | +6.05% | 18.59M | $11.14B | — | — |
| 94 | RGEN | Repligen | 173.88 | +6.13% | 1.34M | $11.04B | 238.2 | — |
| 95 | MDGL | Madrigal Pharmaceuticals | 471.75 | -1.08% | 312.98K | $10.90B | — | — |
| 96 | BMRN | BioMarin Pharmaceutical | 54.80 | -0.17% | 2.15M | $10.61B | 148.1 | — |
| 97 | TWST | Twist Bioscience | 159.78 | +5.08% | 3.54M | $10.59B | — | — |
| 98 | UHS | Universal Health Services | 177.35 | +0.93% | 397.33K | $10.45B | 7.2 | 0.45% |
| 99 | RDY | Dr. Reddy's Laboratories | 12.48 | +2.30% | 1.94M | $10.40B | 27.7 | 0.67% |
| 100 | COO | Cooper Companies | 54.37 | +0.13% | 3.18M | $10.34B | 18.7 | — |
How to use this list
Treat the list as a starting point, not a recommendation. Open each company's page to review its financials, earnings history and news, and compare it with peers. Use the stock screener to narrow the list by valuation, size or dividend yield.
Risks to keep in mind
Lists based on size or index membership concentrate in the largest companies and sectors. Past performance and today's ranking do not predict future returns; diversification and position sizing still matter.
Frequently asked questions
- How many stocks are in the Healthcare Stocks list?
- The list currently contains 100 stocks, as of October 10, 2026.
- Which company ranks first on the Healthcare Stocks list?
- Eli Lilly (LLY) ranks first, with a market capitalization of about $1.1T.
- What is the combined market value of the Healthcare Stocks?
- The 100 companies with market cap data are worth about $8.11T combined.
- What is the average dividend yield on this list?
- 51 companies on the list pay a dividend, with an average yield of 2.18%.
- How often is this list updated?
- Prices and daily changes refresh throughout the trading day with a delay of at least 15 minutes. Membership and rankings are recalculated daily after the close.
Related lists
Learn how to research stocks →
Data as of October 10, 2026. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer